LUPIN
Quarterly Results Analysis [Mar2025]
LUPIN Quarterly Results
Consolidated | Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹5,667 Cr | ₹5,768 Cr | ₹5,673 Cr | ₹5,600 Cr | ₹4,961 Cr | ₹5,197 Cr | ₹5,039 Cr | ₹4,814 Cr |
Expenses | ₹4,346 Cr | ₹4,412 Cr | ₹4,332 Cr | ₹4,359 Cr | ₹3,964 Cr | ₹4,159 Cr | ₹4,121 Cr | ₹3,958 Cr |
Operating Income | ₹1,321 Cr | ₹1,356 Cr | ₹1,340 Cr | ₹1,241 Cr | ₹997 Cr | ₹1,038 Cr | ₹918 Cr | ₹856 Cr |
Other Income | ₹57 Cr | ₹54 Cr | ₹42 Cr | ₹68 Cr | ₹29 Cr | ₹29 Cr | ₹40 Cr | ₹23 Cr |
Interest | ₹89 Cr | ₹67 Cr | ₹71 Cr | ₹68 Cr | ₹71 Cr | ₹74 Cr | ₹81 Cr | ₹86 Cr |
Depreciation | ₹393 Cr | ₹271 Cr | ₹257 Cr | ₹248 Cr | ₹457 Cr | ₹257 Cr | ₹248 Cr | ₹235 Cr |
Profit Before Tax | ₹896 Cr | ₹1,071 Cr | ₹1,055 Cr | ₹993 Cr | ₹498 Cr | ₹736 Cr | ₹630 Cr | ₹559 Cr |
Profit After Tax | ₹782 Cr | ₹859 Cr | ₹859 Cr | ₹806 Cr | ₹368 Cr | ₹619 Cr | ₹495 Cr | ₹453 Cr |
EPS | ₹16.92 | ₹18.74 | ₹18.69 | ₹17.57 | ₹7.89 | ₹13.46 | ₹10.76 | ₹9.94 |
Industry Peers & Returns | 1W | 1M | 1Y |
LUPIN | 2% | -2.2% | 27.9% |
SUN PHARMACEUTICAL INDUSTRIES | 1.6% | -2.9% | 17.2% |
DIVIS LABORATORIES | 1.5% | 10.4% | 51.9% |
CIPLA | 2.3% | 1.9% | 2.8% |
TORRENT PHARMACEUTICALS | 1.4% | 1.3% | 17% |
DR REDDYS LABORATORIES | 5.7% | 14.1% | 15.2% |
MANKIND PHARMA | 0.2% | -2.4% | 12.5% |
ZYDUS LIFESCIENCES | 5.1% | 10.9% | -4.4% |
AUROBINDO PHARMA | 1.5% | -0.2% | -3.3% |
LUPIN Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -1.74 % |
Y-o-Y | 14.24 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹5,667 Cr | -1.74 | |
Dec2024 | ₹5,768 Cr | 1.67 | |
Sep2024 | ₹5,673 Cr | 1.29 | |
Jun2024 | ₹5,600 Cr | 12.89 | |
Mar2024 | ₹4,961 Cr | -4.55 | |
Dec2023 | ₹5,197 Cr | 3.15 | |
Sep2023 | ₹5,039 Cr | 4.66 | |
Jun2023 | ₹4,814 Cr | - |
LUPIN Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -2.56 % |
Y-o-Y | 32.53 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹1,321 Cr | -2.56 | |
Dec2024 | ₹1,356 Cr | 1.16 | |
Sep2024 | ₹1,340 Cr | 8.01 | |
Jun2024 | ₹1,241 Cr | 24.49 | |
Mar2024 | ₹997 Cr | -3.96 | |
Dec2023 | ₹1,038 Cr | 13.09 | |
Sep2023 | ₹918 Cr | 7.18 | |
Jun2023 | ₹856 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -0.85 % |
Y-o-Y | 16.03 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 23.31% | -0.85 | |
Dec2024 | 23.51% | -0.51 | |
Sep2024 | 23.63% | 6.63 | |
Jun2024 | 22.16% | 10.30 | |
Mar2024 | 20.09% | 0.60 | |
Dec2023 | 19.97% | 9.67 | |
Sep2023 | 18.21% | 2.36 | |
Jun2023 | 17.79% | - |
LUPIN Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -8.90 % |
Y-o-Y | 112.48 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹782 Cr | -8.90 | |
Dec2024 | ₹859 Cr | -0.07 | |
Sep2024 | ₹859 Cr | 6.70 | |
Jun2024 | ₹806 Cr | 118.77 | |
Mar2024 | ₹368 Cr | -40.48 | |
Dec2023 | ₹619 Cr | 24.91 | |
Sep2023 | ₹495 Cr | 9.26 | |
Jun2023 | ₹453 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -7.25 % |
Y-o-Y | 86.12 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 13.81 % | -7.25 | |
Dec2024 | 14.89 % | -1.72 | |
Sep2024 | 15.15 % | 5.35 | |
Jun2024 | 14.38 % | 93.80 | |
Mar2024 | 7.42 % | -37.65 | |
Dec2023 | 11.9 % | 21.06 | |
Sep2023 | 9.83 % | 4.35 | |
Jun2023 | 9.42 % | - |
LUPIN Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -9.71 % |
Y-o-Y | 114.45 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹16.92 | -9.71 | |
Dec2024 | ₹18.74 | 0.27 | |
Sep2024 | ₹18.69 | 6.37 | |
Jun2024 | ₹17.57 | 122.69 | |
Mar2024 | ₹7.89 | -41.38 | |
Dec2023 | ₹13.46 | 25.09 | |
Sep2023 | ₹10.76 | 8.25 | |
Jun2023 | ₹9.94 | - |
You may also like the below Video Courses